2027 Invited Speakers

Check back here regularly for newly announced invited speakers.

Register Now

  • Professor Joost Verhoeff

    Amsterdam University Medical Center

    Read More

    Joost Verhoeff, MD PhD, is Professor and Head of the Department of Radiation Oncology at Amsterdam UMC, one of Europe’s largest radiotherapy centers, where he leads a multidisciplinary team advancing precision cancer care. He also serves on the Executive Board of Cancer Center Amsterdam, the Supervisory Board of East Netherlands Radiotherapiegroep, and chairs the Radiation Oncology Science Council (ROSC) of the EORTC.

    His clinical and research work focuses on brain tumors, lung cancer and cardiac arrhythmias, including the European STOPSTORM.eu consortium. His work integrates high-precision radiotherapy, MR-guided radiotherapy, international trial collaboration and data-driven innovation to deliver personalized, quality-of-life-centered treatments.

    Professor Verhoeff’s leadership aligns closely with the TROG 2027 ASM theme, “Connected for Impact”. Through his roles in Amsterdam UMC, EORTC and European collaborative research networks, he brings a strong focus on connecting people, ideas and systems: fostering multidisciplinary teams, supporting innovative trial concepts, and building the partnerships and infrastructure needed to translate radiation medicine research into meaningful clinical impact.

  • Professor Eric Hau

    Westmead and Blacktown Hospital

    Read More

    Eric Hau is a radiation oncologist at Westmead and Blacktown Hospital with interest in lung and brain tumours. He leads the translational radiation biology research program at Westmead Institute of Medical Research

  • Professor Chee Khoon Lee

    St George Hospital

    Read More

    Professor Chee Khoon Lee is a consultant medical oncologist with extensive clinical and research expertise, sub-specialising in thoracic cancers. He is as Senior Staff Specialist and Director of the Medical Oncology Clinical Research Unit at St George Hospital, and Professor of Oncology at The University of Sydney. He serves as the Program Lead of the Thoracic Oncology and Precision Therapeutics at the Sydney Clinical Trials Centre of the University of Sydney Clinical Trials Centre.

    Professor Lee is the study chair or co-chair of nine investigator-initiated, multi-center clinical trials exploring innovative therapies and treatment strategies for thoracic and gynaecological malignancies. Additionally, he has served as principal investigator in over 150 pharmaceutical industry-sponsored studies.

    He is a senior member of the Scientific Advisory Committee of the Thoracic Oncology Group of Australasia (TOGA) and has contributed to various advisory committees for national and international cancer clinical trial collaborative groups. His commitment to academic mentorship is reflected in his supervision of 14 PhD candidates, guiding research in clinical trial methodology and meta-analysis.

    Professor Lee obtained his medical degree with honours from The University of Sydney in 2000. He completed his clinical fellowship training at St George and Prince of Wales Hospitals, and became a Fellow of the Royal Australasian College of Physicians in 2009. His academic qualifications include a Master of Clinical Epidemiology (2004), a Master of Biostatistics (2009), and a Doctor of Philosophy (2012) from The University of Sydney, awarded for his methodological research on improving clinical trial designs involving biomarkers in advanced cancers.

  • Professor Shalini Vinod

    Cancer Therapy Centre, Liverpool Hospital

    Read More

    Prof Shalini Vinod is a senior academic radiation oncologist who specialises in the treatment of patients with lung cancer and other thoracic malignancies. She is employed at the Cancer Therapy Centre, Liverpool Hospital, NSW, Australia and is a Conjoint Professor at the University of New South Wales and Adjunct Professor at University of Sydney.

    Prof Vinod is the lead clinician for the Liverpool & Macarthur Lung Cancer Multidisciplinary Team (MDT). She has particular expertise in health services research including patterns of care studies, radiotherapy utilisation, impact of multidisciplinary care and measurement of quality indicators. She also has a special interest in geriatric oncology. She is co-chair of the MODERN LUNG Phase III clinical trial and clinical lead for the VITaL clinical trial.